***** DFS WEEK 2 *****

555 Views | 7 Replies | Last: 6 yr ago by CrazyAgE
CrazyAgE
How long do you want to ignore this user?
Who's in??? I killed it in DK in week 1....spent $25 and won $150 (all cash games)

I haven't looked into week 2 too much yet. But I'll post back at some point once I look into it more. Until then, if you have any input, please post away!
mAgnoliAg
How long do you want to ignore this user?
AG
Might get back into this
CrazyAgE
How long do you want to ignore this user?
bump!
rtimber
How long do you want to ignore this user?
James White at $4000 is a steal
Tressels Vest
How long do you want to ignore this user?
AG
Wasn't so great last week. Hopefully can earn some back this week.
Floyd Falcon Sr
How long do you want to ignore this user?
AG
Steals on Draftkings this week that I see (Use at your own risk)

Keenan Allen $5800 Saw 10 targets last week
Ty Montgomery $5800 Will be high owned, but really cheap for his usage
Buck Allen $4100 should catch a lot of passes
Larry Fitzgerald $6500 Could lead league in targets this week
Adam Thielen $5000 Dirt cheap for his targets

Others I like (more for tournaments)
Cohen $4100
Desean Jackson $4900 Bears take away WR1 a lot, could see some bombs (maybe stack with Winston)
Alvin Kamara $3500 Tournament only, NE didn't guard hunt well out of backfield. Expect NO to be trailing.



Floyd Falcon Sr
How long do you want to ignore this user?
AG
rtimber said:

James White at $4000 is a steal
Looking even better with Amendola all but ruled out
CrazyAgE
How long do you want to ignore this user?
Floyd Falcon Sr said:

rtimber said:

James White at $4000 is a steal
Looking even better with Amendola all but ruled out
I think Hogan is the better play here, but just by a hair. I'm rolling with Hogan
CrazyAgE
How long do you want to ignore this user?
Here's my preliminary thoughts

P Rivers
M Gordon
Ty Montgomery
T Hill
K Allen
C Kupp
Z Ertz
C Hogan
Seattle D
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.